"An Extra Variable to Consider"—Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials. Issue 5 (9th February 2022)

• Record Type: Journal Article
• Authors: Fatola, Omolayo; Corneli, Amy; Perry, Brian; Hanlen-Rosado, Emily; Nsonwu, Adora; Constantine, Evangelia P; Thompson, Amelia B
• Is Part Of: Journal of the Pediatric Infectious Diseases Society. Volume 11:Issue 5(2022)
• Page Start: 221
• Page End: 224
• Publication Date: 2022-02-09
• Subjects: adolescent -- HIV -- prevention -- vaccine -- VISP; Communicable diseases in children -- Periodicals; Children -- Diseases -- Periodicals; 618.929
• DOI: 10.1093/jpids/piac001
• Languages: English
• ISSNs: 2048-7193

Abstract

Abstract: Our study explores the understanding of vaccine-induced seropositivity (VISP) and its potential impact on US adolescents' and caregivers' willingness to participate in adolescent HIV vaccine clinical trials. Findings from in-depth interviews suggest that addressing concerns about VISP will be essential for future pediatric HIV vaccine trials in the United States. Abstract : Addressing adolescents' and their caregivers' concerns about vaccine-induced seropositivity will likely be essential to the success of future pediatric HIV vaccine trials in the United States.